Sign up for the QMED & MD+DI Daily newsletter.
Pressed for time? Here's the medtech news you need most, in one minute or less.
Amanda Pedersen
April 10, 2020
1 Min Read
Your time is valuable, so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
In response to healthcare workers asking for safer ways to monitor hospitalized diabetes patients with COVID-19, FDA is allowing both Dexcom and Abbott to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the pandemic. This allows frontline healthcare workers in hospitals to remotely monitor patients with diabetes in order to minimize exposure to the virus that causes COVID-19 and preserve use of personal protective equipment. Read more about medtech's response to the global pandemic on our COVID-19 News Central page.
Boston Scientific Recalls Angiographic Catheters
At least nine people have been injured by a faulty cateter tip on Boston Scientific's Imager II 5F Angiographic Catheters, FDA said. The company initiated a recall of the device in February that includes 6,130 of the catheters distributed between July 16, 2018 and Nov. 26, 2019 because the catheter tip can potentially become detached during a procedure or procedure preparation. Click here for a full list of affected lot numbers.
Rushing Supplies to the COVID-19 Forefront
The Global Healthcare Exchange has set up the COVID-19 Information Center to help both healthcare organizations and manufacturers of medical supplies manage any shortages and navigate a a shifting supply chain. The group has also developed a Critical Supply Reference List to help providers identify supplies and potential alternatives as well as offer greater visibility into the fluctuating demand for products.
About the Author(s)
You May Also Like
